Compliance Rate
Compliance Rate
100.0%
Compliant submissions
1
Incompliant submissions
0
Total trials
1
My Organizations' Clinical Trials
Showing 1150 of 2228 entries
View as:
Phase: N/A
Priority: Normal
Start: 02/11/21
End: 04/30/21
Due: 04/30/22
Phase: N/A
Priority: Normal
Start: 03/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/29/19
End: 10/08/20
Due: 10/08/21
Phase: N/A
Priority: Normal
Start: 01/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/31/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 12/31/19
Due: 12/31/20
Phase: N/A
Priority: Normal
Start: 07/22/16
End: 05/30/18
Due: 05/30/19
Phase: N/A
Priority: Normal
Start: 03/31/03
End: 02/28/05
Due: 02/28/06
Phase: N/A
Priority: Normal
Start: 09/30/02
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 02/28/03
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 11/08/18
End: 10/10/19
Due: 10/10/20
Phase: N/A
Priority: Normal
Start: 03/31/05
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/14
End: 07/31/14
Due: 07/31/15
Phase: N/A
Priority: Normal
Start: 12/31/08
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 05/22/17
End: 08/02/17
Due: 08/02/18
Safety, Tolerability and Pharmacokinetics of Oral BIBP 5371 CL in Healthy Male and Female Volunteers
Phase: N/A
Priority: Normal
Start: 04/30/04
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 09/30/12
Due: 09/30/13
Phase: N/A
Priority: Normal
Start: 09/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/27/20
End: 05/08/23
Due: 05/08/24
Phase: N/A
Priority: Normal
Start: 11/07/22
End: 06/20/23
Due: 06/20/24
Phase: N/A
Priority: Normal
Start: 03/13/24
End: 05/15/24
Due: 05/15/25
Phase: N/A
Priority: Normal
Start: 11/30/07
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/98
End: -
Due: -